|
KR0151547B1
(ko)
|
1988-09-06 |
1998-10-15 |
노르버트 에이.코통, 롤란드 보레 |
페닐피리딘 및 이의 제조방법
|
|
US5284956A
(en)
|
1988-09-06 |
1994-02-08 |
Hoffmann-La Roche Inc. |
Liquid crystalline mixtures containing 2-(2-fluorophenyl) pyridines
|
|
WO1999064002A1
(en)
|
1998-06-11 |
1999-12-16 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
CA2377369A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
|
US6890940B2
(en)
|
2001-06-29 |
2005-05-10 |
Kowa Co., Ltd. |
Bis(2-aryl-5-pyridyl) derivatives
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
EP1465867A1
(en)
|
2001-10-09 |
2004-10-13 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
KR20040058307A
(ko)
|
2001-11-26 |
2004-07-03 |
쉐링 코포레이션 |
비만 및 ｃｎｓ 장애를 치료하기 위한 피페리딘계 ｍｃｈ길항제
|
|
AU2003216274A1
(en)
|
2002-02-11 |
2003-09-04 |
Neurocrine Biosciences, Inc. |
Pyrrole derivatives as ligands of melanocortin receptors
|
|
AU2003230367A1
(en)
|
2002-05-10 |
2003-11-11 |
Neurocrine Biosciences, Inc. |
Substituted piperazine as melanocortin receptors ligands
|
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
EP1460073A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
RS53252B
(sr)
|
2003-08-11 |
2014-08-29 |
F.Hoffmann-La Roche Ag. |
Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
|
|
CN1874777B
(zh)
|
2003-09-09 |
2012-07-04 |
弗·哈夫曼-拉罗切有限公司 |
作为甘氨酸摄取抑制剂用于治疗精神病的1-(2-氨基-苯甲酰基)-哌嗪衍生物
|
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
|
US20050119252A1
(en)
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
|
AU2006304305B2
(en)
|
2005-10-18 |
2010-04-01 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
RU2303597C1
(ru)
|
2006-05-12 |
2007-07-27 |
Иващенко Андрей Александрович |
Фармацевтическая композиция, способы ее получения и применения
|
|
ES2522346T3
(es)
*
|
2008-08-22 |
2014-11-14 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de CDK
|
|
CA2735773A1
(en)
|
2008-09-02 |
2010-03-11 |
Neurosearch A/S |
Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
|
|
PL2344474T3
(pl)
|
2008-09-02 |
2016-03-31 |
Novartis Ag |
Pochodne pikolinamidu jako inhibitory kinaz
|
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
TWI598337B
(zh)
|
2009-06-29 |
2017-09-11 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
|
WO2012163354A1
(en)
|
2011-05-31 |
2012-12-06 |
Linak A/S |
Actuator
|
|
FR3017867A1
(fr)
|
2014-02-21 |
2015-08-28 |
Inventiva |
Nouveaux composes de type phenylazetidine carboxylate ou carboxamide
|
|
EP3199156A1
(de)
|
2016-02-01 |
2017-08-02 |
Heinrich-Heine-Universität Düsseldorf |
Verwendung von glycin-transporter-1-antagonisten als zentralnervöse analgetika
|
|
WO2018003962A1
(ja)
|
2016-06-30 |
2018-01-04 |
国立研究開発法人理化学研究所 |
新規化合物又はその薬理学的に許容される塩
|
|
WO2019014460A1
(en)
|
2017-07-12 |
2019-01-17 |
The Brigham And Women's Hospital, Inc. |
MOLECULES ENHANCING EAAT2
|
|
SG11202003407VA
(en)
|
2017-10-17 |
2020-05-28 |
Merck Patent Gmbh |
PYRIMIDINE TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
|
|
AU2019280689B2
(en)
|
2018-06-05 |
2024-09-05 |
Crinetics Pharmaceuticals, Inc. |
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
|
|
US12479825B2
(en)
|
2019-11-07 |
2025-11-25 |
Crinetics Pharmaceuticals, Inc. |
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
|
|
CA3164117A1
(en)
|
2019-12-18 |
2021-06-24 |
Crinetics Pharmaceuticals, Inc. |
Gem-disubstituted piperidine melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
|
|
ES3032933T3
(en)
|
2019-12-23 |
2025-07-29 |
Crinetics Pharmaceuticals Inc |
Spirocyclic piperidine melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
|
|
US11565011B2
(en)
|
2020-09-18 |
2023-01-31 |
Ncr Corporation |
Sterilizing media cassette
|
|
US20230405157A1
(en)
|
2022-05-10 |
2023-12-21 |
Radionetics Oncology, Inc. |
Melanocortin type 2 receptor (mc2r) targeted therapeutics and uses thereof
|